Expected earnings - CytomX Therapeutics Inc.
Source: US Earnings Reports
CytomX Therapeutics Inc. (CTMX) is expected to report $-0.06 for Q2 2025
CytomX Therapeutics Inc.
NASDAQ: CTMX
CTMX Trading
12.73% G/L:
$5.005 Last:
1,989,609 Volume:
$4.58 Open:
CTMX Latest News
March 17, 2026 10:46:40 pm
CytomX Therapeutics Announces Pricing of $250 Million Offering of Common Stock and Pre-Funded WarrantsMarch 16, 2026 06:56:37 pm
Stock Market Today, March 16: CytomX Therapeutics Surges After Positive Phase 1 Colorectal Cancer DataMarch 16, 2026 04:04:55 pm
CytomX Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded WarrantsCTMX Stock Data
$945,449,504
141,817,426
0.97%
31
N/A
Biotechnology & Life Sciences
Healthcare
US
South San Francisco
